CreaGen

CreaGen is a top-tier drug chemistry/drug discovery and contract research organization headquartered in the United States, with 16 years of experience collaborating with over 50 biotech and pharmaceutical companies as well as several federal agencies. Our core expertise lies in the synthesis of new chemical entities, preclinical drug discovery research, scale-up synthesis, and early-stage process development. From the early stages of drug discovery to IND-enabling studies, CreaGen has the technical capabilities to address a wide range of needs in drug discovery, drug product development, and small- to large-scale API synthesis. Additionally, CreaGen possesses specialized knowledge in non-traditional synthetic modalities such as nucleoside and antibody conjugation chemistry. CreaGen's mission is to achieve groundbreaking research, empowering pharmaceutical and biotech companies, academic institutions, and federal research laboratories to advance the frontiers of the pharmaceutical field.